IFNA1 and depressive disorder: Although combination therapy consisting of PEG-IFNα and RBV has been introduced for the treatment of hepatitis C patients, and 50% of individuals infected with genotype 1 achieved a SVR, this treatment is sometimes associated with serious side effects, including depression and anemia [3].